Clinical Significance of CBC and WBC Morphology in the Diagnosis and Clinical Course of COVID-19 Infection

Total Page:16

File Type:pdf, Size:1020Kb

Clinical Significance of CBC and WBC Morphology in the Diagnosis and Clinical Course of COVID-19 Infection AJCP / ORIGINAL ARTICLE Clinical Significance of CBC and WBC Morphology in the Diagnosis and Clinical Course of COVID-19 Infection Olga Pozdnyakova, MD, PhD,1,2 Nathan T. Connell, MD, MPH,2,3, Elisabeth M. Battinelli, MD, PhD,2,3, 2,3 4 1,2 Jean M. Connors, MD, Geoffrey Fell, MS, and Annette S. Kim, MD, PhD Downloaded from https://academic.oup.com/ajcp/advance-article/doi/10.1093/ajcp/aqaa231/6017543 by guest on 05 December 2020 From the 1Department of Pathology and 3Division of Hematology, Department of Medicine, Brigham and Women’s Hospital, Boston, MA; 2Harvard Medical School, Boston, MA; and 4Department of Statistics, Dana Farber Cancer Institute, Boston, MA. Key Words: Peripheral blood; Morphology; Vacuolization; Monocytes; Atypical lymphocytes; COVID-19; SARS-CoV-2; CBC research parameters; Coronavirus Am J Clin Pathol 2020;XX:1–11 DOI: 10.1093/AJCP/AQAA231 ABSTRACT Key Points Objectives: To investigate the clinical significance of • More severe disease in coronavirus disease 2019 (COVID-19)–positive numeric and morphologic peripheral blood (PB) changes patients was associated with more significant neutrophilia and lymphopenia, while more mild disease was associated with more floridly in coronavirus disease 2019 (COVID-19)–positive abnormal monocyte and lymphocyte morphology. patients in predicting the outcome, as well as to compare • Dynamically, patients who ultimately died became progressively more neutrophilic and lymphopenic from diagnosis until the time of demise. these changes between critically ill COVID-19–positive • Research CBC parameters identified differences in intensive care unit and COVID-19–negative patients. patients with and without COVID-19 infection, suggestive of WBC changes due to SARS-CoV-2. Methods: The study included 90 COVID-19–positive (51 intensive care unit [ICU] and 39 non-ICU) patients and 30 COVID-19–negative ICU patients. We collected Severe acute respiratory syndrome coronavirus 2 CBC parameters (both standard and research) and PB (SARS-CoV-2) is the cause of an ongoing pandemic of morphologic findings, which were independently scored by coronavirus disease 2019 (COVID-19), an acute viral two hematopathologists. illness with a spectrum of disease presentation and se- verity.1 During review of peripheral blood of patients Results: All patients with COVID-19 demonstrated striking with COVID-19 admitted to our hospital, we have numeric and morphologic WBC changes, which were different noticed significant alterations of WBC morphology. between mild and severe disease states. More severe disease While there are an increasing number of publications was associated with significant neutrophilia and lymphopenia, and preprints in peer-reviewed and non-peer-reviewed which was intensified in critically ill patients. Abnormal WBC journals regarding COVID-19 pathogenesis, clinical morphology, most pronounced in monocytes and lymphocytes, presentation, and treatment, the studies that have ad- was associated with more mild disease; the changes were lost dressed the morphologic changes in peripheral blood with disease progression. Between COVID-19–positive and associated with SARS-CoV-2 are all limited to case and COVID-19–negative ICU patients, significant differences in image reports.2-5 The most recent study by Nazarullah morphology-associated research parameters were indicative et al6 that includes a detailed quantitative and quali- of changes due to the severe acute respiratory syndrome tative analysis of peripheral blood changes was con- coronavirus 2 virus, including higher RNA content in ducted on 12 COVID-19–positive patients. In addition, monocytes, lower RNA content in lymphocytes, and smaller very few studies provide correlation between peripheral hypogranular neutrophils. blood WBC morphologic changes and disease out- Conclusions: Hospitalized patients with COVID- comes and address the dynamics of CBC parameters 19 should undergo a comprehensive daily CBC with and morphology.2 manual WBC differential to monitor for numerical and Viral-induced numeric and morphologic changes in morphologic changes predictive of poor outcome and signs the peripheral blood WBC are well characterized in other of disease progression. infections and can direct diagnostic workup to ensure © American Society for Clinical Pathology, 2020. All rights reserved. Am J Clin Pathol 2020;XX:1-12 1 For permissions, please e-mail: [email protected] DOI: 10.1093/ajcp/aqaa231 Pozdnyakova et al / PERIPHERAL BLOOD FINDINGS IN COVID-19 timely therapeutic intervention. For example, in infec- severe sepsis and/or acute respiratory distress syndrome tious mononucleosis, caused by the Epstein-Barr virus, to parallel the respiratory distress found in the COVID- there is a significant lymphocytosis with the presence of 19–positive ICU cohort. Overall, 70% of COVID-19– large atypical lymphocytes, termed Downey cells,7 while negative ICU patients had bacterial infections, with one in human immunodeficiency virus infection, the lympho- patient with concurrent influenza B infection. The under- cytes are morphologically unremarkable in the setting of lying comorbidities included cardiovascular disease (80% lymphopenia.8 of patients), ischemic or nonischemic heart failure (65% This study presents a systematic analysis of pe- of patients), diabetes (25% of patients), and atrial fibril- ripheral blood CBC, including standard and research lation (20% of patients). To ensure there were no other Downloaded from https://academic.oup.com/ajcp/advance-article/doi/10.1093/ajcp/aqaa231/6017543 by guest on 05 December 2020 parameters, as well as morphologic findings in 90 con- hospital-based confounding factors that would have secutive patients with COVID-19. Importantly, the skewed the results, we chose patients who were contempo- study compares the peripheral blood findings between raneously in the ICU with other patients with COVID-19 patients with COVID-19 in the intensive care unit (ICU) (but COVID-19 negative themselves). and non-ICU settings, as well as between COVID-19– Routine CBC with WBC differential was per- positive ICU and COVID-19–negative ICU patients, formed on or near the date of COVID-19 diagnosis and demonstrates significant differences between these (confirmed by SARS-CoV-2 reverse transcription pol- two groups, suggesting an important role of CBC with ymerase chain reaction) and/or admission date (for manual smear review in patient risk stratification. To transferred patients) on Sysmex XN-9000 hematology our knowledge, this is the first study to monitor dy- analyzers as a part of routine clinical care. An auto- namic changes in CBC numeric and morphology mated six-part WBC differential included absolute parameters in COVID-19–positive patients who died of count of lymphocytes, monocytes, neutrophils, eosino- the disease and to investigate morphology-associated phils, basophils, and immature granulocytes, the latter research parameters measured by hematology ana- representing an automated count of promyelocytes, lyzers and compare them between COVID-19–positive myelocytes, and metamyelocytes in peripheral blood. and COVID-19–negative patients. Research parameters associated with neutrophil, lym- phocyte, and monocyte morphology (neutrophil lateral scatter light intensity [NE-SSC], neutrophil fluores- cent light intensity [NE-SFL], neutrophil forward Materials and Methods scatter light intensity [NE-FSC], lymphocyte lateral The study included 90 consecutive patients with scattered light intensity [LY-X], lymphocyte fluores- COVID-19 admitted to our hospital between March cent light intensity [LY-Y], lymphocyte forward scat- 14, 2020, and April 14, 2020, as well as 30 ICU patients tered light intensity [LY-Z], monocyte lateral scattered negative for COVID-19. The study was approved by the light intensity [MO-X], monocyte fluorescent light Institutional Human Research Committee. Clinical pre- intensity [MO-Y], monocyte forward scattered light sentation of patients with COVID-19 varied from mild intensity [MO-Z]), measured on Sysmex-XN hema- to severe disease: 51 patients were admitted to the ICU, tology analyzers but not reported as a part of CBC, and 39 patients were followed in the non-ICU settings. were collected in addition to the routine CBC param- There were no significant differences in underlying eters. WBC morphology was analyzed as changes from comorbidities between COVID-19–positive ICU and normal expected/baseline morphology by two inde- non-ICU patients, with hypertension and cardiovascular pendent board-certified hematopathologists (O.P. and disease being the most common (39% vs 36%, respec- A.S.K.) to review individual abnormal features not tively), followed by diabetes (21% vs 15%, respectively). encapsulated in the differential count and/or the ad- Nonhematologic malignancy was present in 15% in both vanced research parameters. The morphologic changes groups, and hematologic malignancy was present in 12% for neutrophils included toxic granulation, cytoplasmic of ICU patients (6% in remission) and 5% of non-ICU vacuolization, Howell-Jolly body-like inclusions, and patients. Acute kidney injury was present in 6% and Döhle bodies; for monocytes, the changes included the 5%, respectively. Approximately 15% of patients in both presence of large coalescing cytoplasmic vacuoles; for groups did not have significant underlying comorbidities. lymphocytes, the changes included the presence of cy- The ICU patients negative for COVID-19 included toplasmic vacuoles, large granular lymphocytes, and age- and sex-matched
Recommended publications
  • Complete Blood Count in Primary Care
    Complete Blood Count in Primary Care bpac nz better medicine Editorial Team bpacnz Tony Fraser 10 George Street Professor Murray Tilyard PO Box 6032, Dunedin Clinical Advisory Group phone 03 477 5418 Dr Dave Colquhoun Michele Cray free fax 0800 bpac nz Dr Rosemary Ikram www.bpac.org.nz Dr Peter Jensen Dr Cam Kyle Dr Chris Leathart Dr Lynn McBain Associate Professor Jim Reid Dr David Reith Professor Murray Tilyard Programme Development Team Noni Allison Rachael Clarke Rebecca Didham Terry Ehau Peter Ellison Dr Malcolm Kendall-Smith Dr Anne Marie Tangney Dr Trevor Walker Dr Sharyn Willis Dave Woods Report Development Team Justine Broadley Todd Gillies Lana Johnson Web Gordon Smith Design Michael Crawford Management and Administration Kaye Baldwin Tony Fraser Kyla Letman Professor Murray Tilyard Distribution Zane Lindon Lyn Thomlinson Colleen Witchall All information is intended for use by competent health care professionals and should be utilised in conjunction with © May 2008 pertinent clinical data. Contents Key points/purpose 2 Introduction 2 Background ▪ Haematopoiesis - Cell development 3 ▪ Limitations of reference ranges for the CBC 4 ▪ Borderline abnormal results must be interpreted in clinical context 4 ▪ History and clinical examination 4 White Cells ▪ Neutrophils 5 ▪ Lymphocytes 9 ▪ Monocytes 11 ▪ Basophils 12 ▪ Eosinophils 12 ▪ Platelets 13 Haemoglobin and red cell indices ▪ Low haemoglobin 15 ▪ Microcytic anaemia 15 ▪ Normocytic anaemia 16 ▪ Macrocytic anaemia 17 ▪ High haemoglobin 17 ▪ Other red cell indices 18 Summary Table 19 Glossary 20 This resource is a consensus document, developed with haematology and general practice input. We would like to thank: Dr Liam Fernyhough, Haematologist, Canterbury Health Laboratories Dr Chris Leathart, GP, Christchurch Dr Edward Theakston, Haematologist, Diagnostic Medlab Ltd We would like to acknowledge their advice, expertise and valuable feedback on this document.
    [Show full text]
  • Intraleukocytic Yeast Inclusions and Toxic Granulation Neutrophils On
    ISSN: 2474-3658 Miglietta et al. J Infect Dis Epidemiol 2019, 5:067 DOI: 10.23937/2474-3658/1510067 Volume 5 | Issue 1 Journal of Open Access Infectious Diseases and Epidemiology CASE REPORT Intraleukocytic Yeast Inclusions and Toxic Granulation Neutrophils on Peripheral Blood Smear: An Interesting Synergy between Hema- tology and Microbiology Fabio Miglietta1, Claudio Palumbo1, Fernando Parente2, Luciano Velardi3, Rosella Matera4, Luigi Conte4, Michela Dargenio4, Maurizio Quarta5, Milva Maria Nuzzo5, Nicola Di Renzo4 and Giambattista Lobreglio6 1Laboratory of Microbiology, Vito Fazzi Regional Hospital, Lecce, Italy 2Medicine Unit, Vito Fazzi Regional Hospital, Lecce, Italy 3Istituto di Nanotecnologia, CNR-Nanotec, Bari, Italy Check for 4Department of Hematology, Vito Fazzi Regional Hospital, Lecce, Italy updates 5Infectious Diseases Unit , Vito Fazzi Regional Hospital, Lecce, Italy 6Laboratory of Clinical Pathology, Vito Fazzi Regional Hospital, Lecce, Italy *Corresponding authors: Dr. Fabio Miglietta, Laboratory of Microbiology, Vito Fazzi Regional Hospital, 83, Montegrappa Street, 73018, Squinzano, Lecce, Italy, Tel: +39-3492548568, Fax: +39-0832782033 by poor sensitivity and slow turn-around time [2] while Abstract β-D-glucan detection demonstrates variable sensitivity The presence of yeast neutrophil inclusions was observed depending on the cut-off diagnostic value and on and discussed several times in other reports; moreover some works demonstrated how Toxic Granulation Neutrophils the Candida species under consideration. This last
    [Show full text]
  • The Significance of Various Granulocytic Inclusions
    4/8/19 THE SIGNIFICANCE OF VARIOUS DISCLOSURES GRANULOCYTIC INCLUSIONS ¡ No relevant financial interests to disclose. KRISTLE HABERICHTER, DO, FCAP GRAND TRAVERSE PATHOLOGY, PLLC OBJECTIVES GRANULOCYTES ¡ Innate immune system ¡ Travel to sites of infection, recognize and phagocytose pathogens ¡ Recognize common and uncommon granulocytic inclusions, including those associated with certain ¡ Utilize numerous cytotoxic mechanisms to kill pathogens inherited disorders and infectious etiologies ¡ Granulopoiesis occurs in the bone marrow ¡ Sufficient stem cells, adequate microenvironment, and regulatory factors ¡ Identify newly described green neutrophilic inclusions ¡ Granulocyte colony stimulating factor (G-CSF) → Granulocytes ¡ Monocyte colony stimulating factor (M-CSF) → Monocytes ¡ Understand the clinical significance and implications of various inclusions ¡ Granulocyte-monocytes colony stimulating factor (GM-CSF) → Granulocytes & Monocytes ¡ 1-3 weeks for complete granulopoiesis to occur ¡ Neutrophils only circulate for a few hours before migrating to the tissues Photo by K. Haberichter (Giemsa, 1000x) GRANULOCYTES INCLUSION CATEGORIES ¡ Primary granules → Myeloperoxidase Reactive/Acquired Changes Congenital Abnormalities Infectious Etiologies ¡ “Late” myeloblasts and promyelocytes ¡ To x ic G r a n u la t io n ¡ Chédiak-Higashi Syndrome ¡ Anaplasma ¡ Secondary granules → Leukocyte alkaline phosphatase ¡ Döhle Bodies ¡ Alder-Reilly Anomaly ¡ Ehrlichia ¡ Myelocytes, metamyelocytes, band and segmented neutrophils ¡ Cytokine Effect ¡ May-Hegglin
    [Show full text]
  • Correlation of Granularity Index with Toxic Granulation of Neutrophils by Manual Microscopy and C-Reactive Protein
    IOSR Journal of Dental and Medical Sciences (JDMS) ISSN: 2279-0853, ISBN: 2279-0861. Volume 3, Issue 2 (Nov.- Dec. 2012), PP 35-39 www.iosrjournals.org Correlation of granularity index with toxic granulation of neutrophils by manual microscopy and C-reactive protein 1Vaddatti Tejeswini, 2Sreenivasulu Kande, 3P. Premalatha, 4T. Rayapa reddy .(Pathology,NRIMC&GH, NTRUHS, India) [1] (Pathology, NRIMC&GH, NTRUHS, India) [2] (Pathology, NRIMC&GH, NTRUHS, India)[3] .(Pathology,NRIMC&GH, NTRUHS, India)[4] Abstract: Background:During inflammation there is increase in plasma concentrations of C Reactive Protein(CRP) along with appearance of toxic granulation neutrophils(TGNs) in the peripheral blood. The granularity of TGNs are graded according to their intensity by manual microscopy. Granularity index(GI) of neutrophils calculated by SEIMENS ADVIA 2120 measures the intensity of neutrophilic granules. Aim: The objective of the present study is to evaluate if GI-Index correlates with TGNs and plasma CRP levels. Materials And Methods: In 228 patients TGNs, GI-Index and CRP were determined. TGNs was graded in Giemsa stained peripheral blood smears, by manual microscopy using a newly proposed grading system. GI- Index calculated by SEIMENS ADVIA 2120, as a quantitative measure from NEUTX values. CRP levels estimated by turbidometry. Results: The samples were analysed and compared with Pearson’s coefficient of correlation(r). There was statistically significant correlation between GI index and grading of TGNs ( n= 228; r= 0.723; p<0.0001 ). The correlation of GI index and CRP was positive but less significant ( n= 228; r= 0.371; p< 0.0001 ) probably due to variation in the extent and cause of inflammation.
    [Show full text]
  • Chronic Lymphocytic Leukaemia
    put together by Alex Yartsev: Sorry if i used your images or data and forgot to reference you. Tell me who you are. [email protected] Chronic Lymphocytic Leukaemia 4.02 Detailed History of Presenting Illness – Leukaemia in general HPI: PI: - Fatigue - Frequent Infections - Weakness - Past Radio/Chemotherapy - Malaise - Past Cancers - Fever Family/Social: - Nightsweats - Leucaemia - Weight loss - Jaundice - Smoking - Lymphadenopathy - Alcohol - Bone pain - CURRENT MEDICATIONS - Excessive bruising - Abdominal pain/swelling/”fullness” Patient’s AGE speaks volumes: !! IMPORTANT: get IIIMMMMUUNNIIISSAATTIIIOONN history !! - The YOUNG get ALL Differential Diagnoses (DDx) - The OLD get CLL + AML - Chronic Infection - Non-leukaemia cancer - Everyone gets - Hypersplenism everything else - Paraneoplastic GM-CSF production - Lymphoma - Anaemia - Depression Pertinent findings on Examination Leukaemia in General Any Leukaemia AML Only - Pallor or Jaundice - swollen, painful, and bleeding gums - - splenomegaly mets to the oral tissue; - hepatomegaly - pigmented (colored) rash-like spots - - abdominal swelling. mets to the skin; or - Lymphadenopathy - chloromas (granulocytic sarcomas; Advanced: Mets Brain collections of tumorous cells within the - central nervous system effects: skin or other body parts) - headaches - ecchymoses, epistaxis, or menorrhagia - seizures - weakness - blurred vision The T-cell variety of (ALL) may cause the - balance difficulties thymus to enlarge and press on the trachea - vomiting or the superior vena cava .
    [Show full text]
  • Hematology for Family Practice When to Treat and When to Refer
    Hematology for Family Practice When to treat and when to refer Karen deGenevieve MSN, FNP,BC OCN Objectives: 1. Identify types of anemia's by analyzing indices, and appropriate tests. 2. Understand manual differential and terminology. 3. Discuss abnormalities in platelets and white cells, and determine appropriate testing. Objectives continued: 4. Discuss treatment options for hematologic conditions and medication management. 5. Know when to refer. 1. Anemia's and Erythrocytosis 2. Low platelets and High platelets 3. Leukopenia's and Leukocytosis How long do cells live? • Red blood cells live approximately 120 days. • Platelets live 8 -11 days. • White blood cells live about 4 days. There are millions of RBCs in just one drop of blood. People who live at higher altitudes have more (like in the mountains of Peru). They are produced in the bone marrow of large bones at a rate of 2 million per second. In the minute it took you to read this, you made 120 million of them! Anemia’s And Erythrocytosis First thing to do with an abnormal CBC is to repeat it and get a smear to pathology, manual diff, and reticulocyte count. MICROCYTOSIS: Low MCV (mean corpuscular volume) under 80. Low MCH (mean corpuscular hemoglobin) under 27. Low MCHC (mean corpuscular hemoglobin concentration) under 30. MACROCYTOSIS: High MCV over 93 High MCH over 33 High MCHC over 37 NORMOCYTIC ANEMIA: NOMAL INDICIES DEFINITIONS Reticulocyte: The youngest of the circulating red cells, normally they comprise about 1% of the red cell population. They are increased in response to bleeding, or hemolysis, or in response to treatment with B 12, iron, of folic acid.
    [Show full text]
  • Serum Procalcitonin and Neutrophil Toxic Granules Guided Management of Post-Operative K. Pneumoniae Septic-Shock in Laminectomy—A Case Report
    Advances in Infectious Diseases, 2012, 2, 72-75 http://dx.doi.org/10.4236/aid.2012.23011 Published Online September 2012 (http://www.SciRP.org/journal/aid) Serum Procalcitonin and Neutrophil Toxic Granules Guided Management of Post-Operative K. pneumoniae Septic-Shock in Laminectomy—A Case Report Indira Chivukula1, Paul K. Marx1, Kamaraju S. Ratnakar2, G. Subbaiah3, Venkataraman Sritharan1* 1Molecular Diagnostics and Biomarkers Laboratory, Department of Laboratory Medicine, Global Hospitals, Hyderabad, India; 2Aca- demic and Research, Global Hospitals, Hyderabad, India; 3Institute of Orthopedics and Spine Surgery, Hyderabad, India. Email: *[email protected] Received April 3rd, 2012; revised May 5th, 2012; accepted June 7th, 2012 ABSTRACT Introduction: We still rely on clinical diagnosis for initiating empirical antibiotic therapy and await blood culture for confirmation of infection, species identification and drug sensitivity. Differential blood cell count (WBC and neutro- phils) and recording of toxic granules in the neutrophils are established methods for indirect diagnosis of infection though they are not used in the diagnosis of sepsis per se. Serum Procalcitonin is considered as a good biomarker in the management of sepsis. Materials and Methods: Whole blood and serum were used for laboratory analysis. We have combined the detection of toxic granules in the peripheral blood smear and serum PCT levels for diagnosis and moni- toring the recovery of a patient with septic shock. A 63 year old laminectomy patient was transferred 2 days after the surgery to our hospital with several co-morbidities and complications. He was in septic shock and was put on Continu- ous Renal Replacement Therapy, with ionotropic support and IV fluids via nasogastric feeding and administration of Activated Protein C.
    [Show full text]
  • Educational Commentary – Blood Cell Id: Identifying Common Peripheral Blood Cells
    EDUCATIONAL COMMENTARY – BLOOD CELL ID: IDENTIFYING COMMON PERIPHERAL BLOOD CELLS Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click on Earn CE Credits under Continuing Education on the left side of the screen. To view the blood cell images in more detail, click on the sample identification numbers underlined in the paragraphs below. This will open a virtual image of the selected cell and the surrounding fields. If the image opens in the same window as the commentary, saving the commentary PDF and opening it outside your browser will allow you to switch between the commentary and the images more easily. Click on this link for the API ImageViewerTM Instructions. Learning Outcomes On completion of this activity, the participant should be able to: • describe the significant morphologic features of common peripheral blood cells. • discuss characteristics of red blood cell and platelet morphologic variations. Case Study A 78 year old female was seen in the emergency room for leg pain. The CBC results are as follows: WBC=18.2 x 109/L, RBC=3.43 x 1012/L, Hgb=10.1 g/dL, Hct=35.6%, MCV=103.8 fL, MCH=29.3 pg, MCHC=28.2 g/dL, RDW=22.0%, Platelet=2615 x 109/L. Educational Commentary The images presented in this testing event represent normal white blood cells and platelets that may be seen in the peripheral blood. In addition, photographs of an abnormality in platelets and another with erythrocytes are presented for educational review and discussion.
    [Show full text]
  • Blood Smear Basics
    BLOOD SMEAR BASICS JENNIFER A. NEEL, DVM, DACVP (CLINICAL) ASSOCIATE PROFESSOR, CLINICAL PATHOLOGY NC STATE COLLEGE OF VETERINARY MEDICINE RALEIGH, NC, 27607 Introduction Although tremendous advances have been made in the field of point-of-care hematology analyzers, examination of a well prepared, well stained blood smear remains the cornerstone of veterinary diagnostic hematology. Even the most sophisticated hematology instruments are unable to consistently provide accurate differential cell counts, and no analyzer is capable of accurately identifying morphology changes, hemoparasites, neoplastic cells, etc. This review will cover the basics of how to approach blood smear evaluation in a consistent and systematic manner and will focus on recognition of clinically significant findings. Making a quality blood smear Although there are several techniques described for making blood smears, most people use the wedge or push technique. Always start with room temperature, well-mixed, clot free, EDTA anticoagulated blood (heparin is used for some exotic species). If the blood has been refrigerated, allow it to return to room temperature. The best slides to use for making blood smears are the premium, pre-cleaned kind; those with a frosted end also facilitate easy labeling. If you are not using premium pre-cleaned slides, you will need to wipe off each slide you plan to use for making the blood smear, including spreader slides, in order to eliminate glass grit and dust which can ruin your smear. Always mix the specimen immediately before making the smear by gently rolling the tube several times to ensure good cellular distribution, don’t shake or invert. To transfer blood from the tube to the slide, fill a plain microhematocrit tube with blood by capillary action and place a finger over the end to prevent the blood from running out.
    [Show full text]
  • California Association for Medical Laboratory Technology Distance Learning Program
    California Association for Medical Laboratory Technology Distance Learning Program NEUTROPHILIA by Helen M. Sowers, MA, CLS Dept. of Biological Science (retired) California State University, East Bay Hayward, CA Dora W. Goto, MS, CLS, MT(ASCP) Laboratory Manager Bay Valley Medical Group Hayward, CA Course DL-989 1.0 CE/Contact Hour Level: Basic © California Association for Medical Laboratory Technology. Permission to reprint any part of these materials, other than for credit from CAMLT, must be obtained in writing from the CAMLT Executive Office. CAMLT is approved by the California Department of Health Services as a CA CLS Accrediting Agency (#0021) and this course is approved by ASCLS for the P.A.C.E.® Program (#519) 1895 Mowry Ave - Suite 112, Fremont, CA 94538 Phone – 510-792-4441 Fax – 510-792-3045 Notification of Distance Learning Deadline All continuing education units required to renew your license must be earned no later than the expiration date printed on your license. If some of your units are made up of Distance Learning courses, please allow yourself enough time to retake the test in the event you do not pass on the first attempt. CAMLT urges you to earn your CE units early! CAMLT Distance Learning Course DL-989 1 © California Association for Medical Laboratory Technology NEUTROPHILIA ABSTRACT: The production and distribution of normally functioning neutrophils is vital to host defenses. In order to understand the normal condition compared to changes that occur in disease states, the development, structure, function, and kinetics of neutrophils will be discussed. There are a number of causes for increase in neutrophils.
    [Show full text]
  • For Peer Review 19 We Identified and Reviewed Published Cases of Chronic Neutrophilic Leukaemia Without an 20 Apparent Coexisting Plasma Cell Neoplasm
    British Journal of Haematology Chronic neutrophilic l eukaemia and plasma cell -related neutrophilic leukaemoid reactions Journal:For British Peer Journal of Haematology Review Manuscript ID: Draft Manuscript Type: Ordinary Papers Date Submitted by the Author: n/a Complete List of Authors: Bain, Barbara; St Mary's Hospital, Haematology MGUS, MULTIPLE MYELOMA, CHRONIC LEUKAEMIA, CHRONIC Key Words: NEUTROPHILIC Page 1 of 26 British Journal of Haematology 1 2 3 Chronic neutrophilic leukaemia and plasma cell-related neutrophilic leukaemoid reactions 4 5 1 2 6 Barbara J. Bain and Shahzaib Ahmad 7 1Department of Haematology, Imperial College Healthcare NHS Health Trust and Centre 8 for Haematology, St Mary’s Hospital campus of Imperial College London, St Mary’s 9 2 10 Hospital, Praed Street, London, W2 1NY and Barts and the London School of Medicine 11 and Dentistry, Queen Mary University of London, St Batholomew's Hospital, London 12 EC1A 7BE , UK. 13 14 15 Summary 16 17 Many cases reported as ‘chronic neutrophilic leukaemia’ have had an associated plasma 18 cell neoplasm. RecentFor evidence Peer suggests that Reviewthe great majority of such cases represent a 19 neutrophilic leukaemoid reaction to the underlying multiple myeloma or monoclonal 20 gammopathy of undetermined significance. We have analysed all accessible reported 21 cases to clarify the likely diagnosis and to ascertain whether toxic granulation, Döhle 22 23 bodies and an increased neutrophil alkaline phosphatase score were useful in making a 24 distinction between chronic neutrophilic leukaemia and a neutrophilic leukaemoid 25 reaction. We established that all these changes occur in both conditions. Toxic 26 granulation and Döhle bodies are more consistently present in leukaemoid reactions but 27 28 also occur quite frequently in chronic neutrophilic leukaemia.
    [Show full text]
  • The Complete Blood Count Cord May Result in an Elevated Common Laboratory Tests Ordered Hematocrit and Transitory Poly- 5,6,9 During the Neonatal Period
    .Lab Values. HE complETE blood count late clamping of the umbilical T(CBC) is one of the more The Complete Blood Count cord may result in an elevated common laboratory tests ordered hematocrit and transitory poly- 5,6,9 during the neonatal period. The Terri Lynne Milcic, RNC, NNP-BC cythemia. Values can vary CBC may be obtained to evaluate between sample sites. For example, for anemia, infection, and throm- EDITOR capillary samples have approxi- bocytopenia.1 The test offers a mately an 82 percent correlation wealth of clinical information Patricia Nash, MSN, NNP-BC with venous samples and approxi- about the hematopoietic system, mately a 77 percent correlation including erythrocyte, leuko- with arterial samples, with the cyte, and thrombocyte values. Establishing normal neonatal capillary site having a higher hemoglobin concentration and ranges has been difficult because blood has not been drawn hematocrit value due to the sludging of RBCs in the low-flow on healthy neonates of similar ages.2 Reference ranges that capillaries and transudation of plasma.10 The sample site must consist of the 5th to 95th percentile compiled from various be taken into consideration when the practitioner reviews the studies have been used to approximate normal neonatal CBC because it can impact the intervention. For example, a values.3 A variety of factors such as sample site, timing of the capillary sample may reveal an elevated hemoglobin level and sample, gestational age, and the neonate’s degree of health hematocrit percentage, an indicator of polycythemia. In this can affect the CBC.1 Therefore, the astute practitioner must situation, an arterial or venous sample would give a more be able to recognize the clues and nuances of the CBC to accurate value.11,12 Neutrophil counts can be affected by the guide the diagnostic assessment.4 type of delivery the infant experienced and the timing of the sample.
    [Show full text]